False Advertising Laws: What Marketers Get Wrong

False advertising laws prohibit marketers from making claims about products or services that are misleading, unsubstantiated, or likely to deceive consumers. In the United States, the Federal Trade Commission (FTC) is the primary enforcement body, with authority to investigate deceptive practices, issue fines, and require corrective advertising. Similar frameworks exist in the UK through the Advertising Standards Authority (ASA) and the Competition and Markets Authority (CMA), and across the EU under the Unfair Commercial Practices Directive.

Most marketing teams are not deliberately dishonest. The problem is more subtle than that. Claims drift. Enthusiasm outpaces evidence. Someone writes a headline that sounds compelling, and nobody stops to ask whether it can be substantiated. That gap between what you want to say and what you can prove is where most legal exposure actually lives.

Why This Is a Strategy Problem, Not Just a Legal One

When I was judging the Effie Awards, I saw entries that made extraordinary claims about campaign effectiveness. Some were legitimate. Others were constructed in ways that would never survive scrutiny in a courtroom or a regulator’s office. The entrants were not always being cynical. Some genuinely believed their own narrative. They had confused correlation with causation, or selected the time window that made their numbers look best, and then written it up as proof. Nobody in the room had asked the hard question: can we actually substantiate this?

That same dynamic plays out in live marketing every day. A brand team wants to say their product is “the UK’s favourite.” A performance team wants to claim “results in 30 days.” A founder wants to put “clinically proven” on the packaging. These are not unusual claims. They are also not automatically legal ones. The question is always the same: what evidence exists, and does the claim accurately represent that evidence?

False advertising law is, at its core, about the relationship between claims and evidence. Get that relationship right, and you are protected. Get it wrong, and the legal exposure is the least of your problems. The reputational damage, the corrective advertising orders, the competitor PR opportunities, those tend to be more commercially damaging than the fine itself.

If you are building or refining your go-to-market approach, it is worth reading the broader thinking on Go-To-Market and Growth Strategy at The Marketing Juice. Compliance is not a constraint on good strategy. It is part of what makes strategy durable.

What Counts as a False Advertising Claim?

The legal definition is broader than most marketers assume. A false advertising claim is not limited to statements that are factually incorrect. It includes any representation that is likely to mislead a reasonable consumer, even if every word is technically true.

The FTC identifies two categories of problematic claims. The first is literally false statements: claims that are factually incorrect on their face. The second, and more common, is misleading claims: statements that are technically accurate but create a false impression through omission, emphasis, or framing. Courts and regulators have consistently held that the second category is just as actionable as the first.

A few examples that illustrate the boundary:

• “Nine out of ten dentists recommend” is a classic claim format. It is legal if the survey was conducted properly, the sample was representative, and the question was asked fairly. It is not legal if the survey was conducted among ten dentists who happened to be employees of the brand.
• “Our supplement supports immune health” is permissible in the US under FTC and FDA guidance, with appropriate caveats. “Our supplement prevents colds” is a disease claim that requires clinical substantiation the vast majority of supplement brands do not have.
• “Up to 50% off” is legal if at least some products are 50% off. It becomes deceptive if the only item at 50% off is one discontinued product nobody wants.

The pattern in all three cases is the same. The claim is constructed to create an impression that the underlying evidence does not fully support. Regulators look at the net impression on a reasonable consumer, not the literal parsing of individual words.

The Substantiation Requirement Most Teams Miss

In the United States, the FTC’s substantiation doctrine requires that advertisers have a reasonable basis for objective claims before those claims are published. Not after a complaint is filed. Before.

This is the part that catches teams out. The assumption in many marketing departments is that a claim is fine until someone challenges it. That is not how the law works. The obligation to substantiate runs before publication. If you cannot point to the evidence that supports your claim at the time you make it, you are already in breach, regardless of whether anyone complains.

What counts as reasonable substantiation depends on the nature of the claim. For general marketing puffery (“we’re passionate about coffee”), no substantiation is required because no reasonable consumer takes it as a factual assertion. For objective claims about performance, efficacy, safety, or comparative superiority, the bar is higher. For health and safety claims, it is higher still, often requiring controlled studies conducted by qualified researchers.

I have worked with clients across more than 30 industries, and the substantiation gap tends to show up in the same place every time: the moment when a brief moves from strategy into copy. The strategist writes “market-leading performance” as a positioning direction. The copywriter takes it literally and puts it in the headline. Nobody asks what evidence supports “market-leading.” Nobody owns that question. It goes live. That is a process failure, not a knowledge failure.

Comparative Advertising: Legal, but Precise

Comparative advertising, where you name a competitor and claim superiority, is legal in the United States and most of Europe. It is also one of the highest-risk areas of marketing communications from a false advertising standpoint.

The reason is simple. When you make a comparative claim, you are making a factual assertion about someone else’s product as well as your own. You are now liable not just for the accuracy of your own data but for the fairness of the comparison. If you compare your product under conditions that favour yours and disadvantage the competitor’s, that is a deceptive comparison even if your individual data points are accurate.

The Lanham Act in the United States allows competitors to sue for false advertising in comparative campaigns. This is not a theoretical risk. Competitor litigation over comparative claims is relatively common in categories like consumer electronics, automotive, and fast-moving consumer goods. The cost of defending a Lanham Act claim, even a successful defence, is significant.

The practical standard for comparative advertising is this: the comparison must be fair, accurate, and based on data that can be independently verified. If you are comparing on a metric that you chose specifically because it makes you look good, a regulator or a court is likely to see through that. The framing that matters is not “is this technically accurate?” but “does this give a fair impression of how the products compare?”

Social Proof, Influencers, and Endorsements

The FTC’s guidelines on endorsements and testimonials have been progressively strengthened over the past decade, and enforcement has become more active. The core requirement is disclosure: any material connection between an endorser and a brand must be clearly and conspicuously disclosed.

A material connection includes payment, free products, employment, family relationships, and any other benefit that might affect how a consumer evaluates the endorsement. The disclosure must be clear enough that a typical consumer would notice and understand it. Burying “#ad” in a list of hashtags does not meet the standard. Neither does a disclosure that appears after the fold on a long post.

There are a few specific areas where teams regularly get this wrong:

• Employee reviews: If you ask employees to leave positive reviews on third-party platforms without disclosing their relationship to the company, that is a deceptive practice under FTC guidance.
• Incentivised reviews: Offering discounts or free products in exchange for reviews creates a material connection that must be disclosed, even if you do not require the review to be positive.
• Influencer reposts: If you repost an influencer’s content on your own channels, and that influencer was compensated, the disclosure obligation follows the content. You cannot strip the disclosure by reposting.
• UGC in paid ads: User-generated content used in paid advertising carries the same disclosure requirements as any other paid endorsement if the creator was compensated.

The FTC updated its endorsement guidelines in 2023, and the direction of travel is clear: more disclosure, more enforcement, higher penalties. This is an area where “we didn’t know” is not a defence that carries much weight.

Health, Environmental, and Performance Claims

Three categories of claims carry disproportionately high regulatory risk: health claims, environmental claims, and specific performance claims. Each has its own regulatory framework, and each is an area where enforcement activity has been increasing.

Health claims in the US are governed by both the FTC and the FDA, and the two agencies have different but overlapping jurisdictions. The FDA regulates what can be said on food, drug, and supplement labels. The FTC regulates advertising. A claim that passes FDA labelling requirements may still be actionable under FTC advertising standards if the advertising context creates a misleading impression. “Clinically proven” is one of the most abused phrases in consumer marketing. It implies a standard of evidence that most products claiming it cannot meet.

Environmental claims are governed in the US by the FTC’s Green Guides, which have been under revision. Terms like “eco-friendly,” “sustainable,” “carbon neutral,” and “natural” all carry substantiation requirements. Vague environmental claims with no supporting evidence are a growing area of regulatory enforcement, particularly in the EU where the Green Claims Directive is moving toward mandatory substantiation for all environmental marketing claims.

Performance claims covering speed, results, savings, or outcomes require evidence that the claimed result is achievable by a typical consumer under normal conditions. “Lose 10 pounds in 10 days” requires evidence that this outcome is typical, not exceptional. “Save up to £500 a year” requires evidence of how that saving is calculated and for what type of customer.

The pattern across all three categories is the same: the claim must reflect the experience of a typical consumer, not the best-case scenario. If your evidence comes from a controlled trial with an atypical population, or from your five best customers, or from conditions that do not reflect normal use, your claim is vulnerable.

The International Dimension

If you are running global campaigns, you are not operating under a single legal framework. False advertising law varies significantly across jurisdictions, and a campaign that is compliant in the US may be non-compliant in Germany, Australia, or Canada.

A few areas where the differences are material:

• Comparative advertising: Broadly permitted in the US and UK, but more restricted in some EU member states, particularly around naming competitors directly.
• Puffery: The concept of non-actionable puffery exists in US law but is interpreted more narrowly in some other jurisdictions. Claims that would be dismissed as obvious exaggeration in the US may be treated as factual assertions elsewhere.
• Children’s advertising: Restrictions on advertising to children vary widely. What is permitted in the US may be prohibited in Sweden, Norway, or Quebec.
• Pricing claims: “Was/now” pricing and reference pricing are regulated differently across markets. The UK’s CMA has been particularly active on misleading pricing practices in e-commerce.

When I was running agency operations that touched multiple markets simultaneously, the practical approach was to build compliance review into the campaign workflow at the brief stage, not at the final approval stage. By the time creative is finished and media is booked, the cost of a compliance-driven revision is significant. Catching it at the brief costs almost nothing.

Building a Claim Substantiation Process

The most effective way to manage false advertising risk is not to hire more lawyers. It is to build a process that catches problematic claims before they reach legal review. Legal review is expensive and slow. A good internal process is neither.

The process I have seen work best has four components:

Claim inventory: Maintain a live list of all claims used in active marketing materials, categorised by type (puffery, objective, comparative, health, environmental) and linked to the substantiation evidence for each. This sounds bureaucratic. It is also the first thing a regulator will ask for if a complaint is filed, and having it ready demonstrates good faith.

Pre-publication substantiation review: Any objective claim that goes into copy must be reviewed against the claim inventory before it goes live. This does not require a lawyer for every piece of content. It requires a trained person with a clear checklist and the authority to pause content that does not meet the standard.

Brief-stage flagging: Train strategists and account managers to flag potential claim issues at the brief stage. “Market-leading,” “best,” “fastest,” “most trusted,” “proven” are all words that should trigger a question: what evidence do we have for this? That question is cheap to ask at the brief stage and expensive to answer after the campaign has run.

Regular audit: Marketing materials age. Evidence that supported a claim two years ago may no longer be current. A quarterly review of active claims against current evidence is a reasonable cadence for most businesses.

This is not about being timid with marketing claims. Strong, specific claims are more effective than vague ones. The goal is to make claims that are both compelling and defensible, not to water everything down into meaninglessness.

What Enforcement Actually Looks Like

Most false advertising enforcement does not start with a regulator. It starts with a competitor complaint, a consumer complaint, or a journalist investigation. Regulators in most jurisdictions are complaint-driven, which means the practical risk is not just regulatory action but the reputational and commercial consequences of a public complaint process.

In the UK, the ASA publishes its rulings publicly. A ruling against your brand is a piece of permanent, indexed content that describes your advertising as misleading. That is a different kind of commercial problem from a fine. Competitors use it in sales conversations. Journalists reference it in coverage. It sits in search results next to your brand name.

In the US, the FTC has the authority to require corrective advertising, which means publishing statements that correct the false impression your original advertising created. The corrective advertising requirement can run for years and is specifically designed to be as visible as the original misleading campaign.

The commercial logic for getting this right is not primarily about avoiding fines. It is about protecting the credibility of your claims. If your advertising is accurate and substantiated, you can defend it confidently. If it is not, you are one competitor complaint away from a process that is expensive, distracting, and publicly damaging regardless of the outcome.

The relationship between compliance and effective go-to-market strategy is closer than most teams appreciate. Sustainable growth comes from claims that build trust over time, not from claims that win a news cycle and then require correction. The broader thinking on Go-To-Market and Growth Strategy at The Marketing Juice explores how durable commercial foundations are built, and claim integrity is part of that foundation.

The Difference Between Legal and Effective

There is a version of this conversation that ends with “make sure your lawyers approve everything” and leaves it there. That is not useful advice for a marketing team trying to produce effective work at pace.

The more useful framing is this: claims that are specific, accurate, and substantiated tend to be more effective than claims that are vague and unverifiable. “Clinically proven to reduce wrinkles in 28 days, in a study of 200 participants” is more credible than “clinically proven.” “Rated number one for customer service by Which? in 2024” is more persuasive than “the UK’s favourite.” Specificity builds credibility. Vagueness invites scepticism.

The discipline of substantiation, asking “what evidence do we have for this?” before every objective claim, is not just a legal exercise. It is a creative discipline. It forces you to find the specific, verifiable truth about your product and express it clearly. That is usually better marketing than the alternative.

I have seen this play out repeatedly across agency work. The clients who invested in understanding what they could genuinely claim, and then built their messaging around those substantiated truths, consistently produced more durable commercial results than the clients who led with aspiration and hoped nobody checked. The former built trust. The latter built a liability.

About the Author

Keith Lacy is a marketing strategist and former agency CEO with 20+ years of experience across agency leadership, performance marketing, and commercial strategy. He writes The Marketing Juice to cut through the noise and share what works.

Frequently Asked Questions